Literature DB >> 19376912

Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease.

Raffaella Di Cagno1, Carlo G Rizzello, Francesca Gagliardi, Patrizia Ricciuti, Maurice Ndagijimana, Ruggiero Francavilla, M Elisabetta Guerzoni, Carmine Crecchio, Marco Gobbetti, Maria De Angelis.   

Abstract

This study aimed at investigating the fecal microbiotas of children with celiac disease (CD) before (U-CD) and after (T-CD) they were fed a gluten-free diet and of healthy children (HC). Brothers or sisters of T-CD were enrolled as HC. Each group consisted of seven children. PCR-denaturing gradient gel electrophoresis (DGGE) analysis with V3 universal primers revealed a unique profile for each fecal sample. PCR-DGGE analysis with group- or genus-specific 16S rRNA gene primers showed that the Lactobacillus community of U-CD changed significantly, while the diversity of the Lactobacillus community of T-CD was quite comparable to that of HC. Compared to HC, the ratio of cultivable lactic acid bacteria and Bifidobacterium to Bacteroides and enterobacteria was lower in T-CD and even lower in U-CD. The percentages of strains identified as lactobacilli differed as follows: HC (ca. 38%) > T-CD (ca. 17%) > U-CD (ca. 10%). Lactobacillus brevis, Lactobacillus rossiae, and Lactobacillus pentosus were identified only in fecal samples from T-CD and HC. Lactobacillus fermentum, Lactobacillus delbrueckii subsp. bulgaricus, and Lactobacillus gasseri were identified only in several fecal samples from HC. Compared to HC, the composition of Bifidobacterium species of T-CD varied, and it varied even more for U-CD. Forty-seven volatile organic compounds (VOCs) belonging to different chemical classes were identified using gas-chromatography mass spectrometry-solid-phase microextraction analysis. The median concentrations varied markedly for HC, T-CD, and U-CD. Overall, the r(2) values for VOC data for brothers and sisters were equal to or lower than those for unrelated HC and T-CD. This study shows the effect of CD pathology on the fecal microbiotas of children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376912      PMCID: PMC2698361          DOI: 10.1128/AEM.02793-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  44 in total

1.  Application of multilocus sequence analysis (MLSA) for rapid identification of Enterococcus species based on rpoA and pheS genes.

Authors:  Sabri M Naser; Fabiano L Thompson; Bart Hoste; Dirk Gevers; Peter Dawyndt; Marc Vancanneyt; Jean Swings
Journal:  Microbiology (Reading)       Date:  2005-07       Impact factor: 2.777

2.  Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice.

Authors:  Volker Mai; Lisa H Colbert; Susan N Perkins; Arthur Schatzkin; Stephen D Hursting
Journal:  Mol Carcinog       Date:  2007-01       Impact factor: 4.784

3.  Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces.

Authors:  Takahiro Matsuki; Koichi Watanabe; Junji Fujimoto; Yukiko Miyamoto; Toshihiko Takada; Kazumasa Matsumoto; Hiroshi Oyaizu; Ryuichiro Tanaka
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 4.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

Authors:  G R Gibson; M B Roberfroid
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease.

Authors:  Catherine E Garner; Stephen Smith; Ben de Lacy Costello; Paul White; Robert Spencer; Chris S J Probert; Norman M Ratcliffe
Journal:  FASEB J       Date:  2007-02-21       Impact factor: 5.191

7.  The intestinal microflora of childhood patients with indicated celiac disease.

Authors:  J Kopecný; J Mrázek; K Fliegerová; P Frühauf; L Tucková
Journal:  Folia Microbiol (Praha)       Date:  2008-07-27       Impact factor: 2.099

8.  Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood.

Authors:  Sarah L Young; Mary A Simon; Margaret A Baird; Gerald W Tannock; Rodrigo Bibiloni; Kate Spencely; Juliette M Lane; Penny Fitzharris; Julian Crane; Ian Town; Emmanuel Addo-Yobo; Clare S Murray; Ashley Woodcock
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  Differences between the fecal microbiota of coeliac infants and healthy controls.

Authors:  María Carmen Collado; Miguel Calabuig; Yolanda Sanz
Journal:  Curr Issues Intest Microbiol       Date:  2007-03

10.  Survival and persistence of Lactobacillus plantarum 4.1 and Lactobacillus reuteri 3S7 in the gastrointestinal tract of pigs.

Authors:  Maria De Angelis; Sonya Siragusa; Leonardo Caputo; Adriano Ragni; Roberto Burzigotti; Marco Gobbetti
Journal:  Vet Microbiol       Date:  2007-02-24       Impact factor: 3.293

View more
  48 in total

1.  Plaque-left-behind after brushing: intra-oral reservoir for antibacterial toothpaste ingredients.

Authors:  Marieke P T Otten; Henk J Busscher; Frank Abbas; Henny C van der Mei; Chris G van Hoogmoed
Journal:  Clin Oral Investig       Date:  2011-12-13       Impact factor: 3.573

Review 2.  Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.

Authors:  Daniel K Chan; Cadman L Leggett; Kenneth K Wang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  Salivary microbiota and metabolome associated with celiac disease.

Authors:  Ruggiero Francavilla; Danilo Ercolini; Maria Piccolo; Lucia Vannini; Sonya Siragusa; Francesca De Filippis; Ilaria De Pasquale; Raffaella Di Cagno; Michele Di Toma; Giorgia Gozzi; Diana I Serrazanetti; Maria De Angelis; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

4.  Hydroxycinnamic acids used as external acceptors of electrons: an energetic advantage for strictly heterofermentative lactic acid bacteria.

Authors:  Pasquale Filannino; Marco Gobbetti; Maria De Angelis; Raffaella Di Cagno
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

5.  Draft genome sequence of Lactobacillus rossiae DSM 15814(T).

Authors:  Raffaella Di Cagno; Maria De Angelis; Federica Cattonaro; Marco Gobbetti
Journal:  J Bacteriol       Date:  2012-10       Impact factor: 3.490

6.  Biofilm formation on stainless steel and gold wires for bonded retainers in vitro and in vivo and their susceptibility to oral antimicrobials.

Authors:  Marije A Jongsma; Floris D H Pelser; Henny C van der Mei; Jelly Atema-Smit; Betsy van de Belt-Gritter; Henk J Busscher; Yijin Ren
Journal:  Clin Oral Investig       Date:  2012-08-02       Impact factor: 3.573

Review 7.  Intestinal microbiota and probiotics in celiac disease.

Authors:  Luís Fernando de Sousa Moraes; Lukasz Marcin Grzeskowiak; Tatiana Fiche de Sales Teixeira; Maria do Carmo Gouveia Peluzio
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 8.  Celiac disease: should we care about microbes?

Authors:  Alberto Caminero; Elena F Verdu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-12       Impact factor: 4.052

9.  Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.

Authors:  Gwen Duytschaever; Geert Huys; Maarten Bekaert; Linda Boulanger; Kris De Boeck; Peter Vandamme
Journal:  Appl Environ Microbiol       Date:  2011-09-16       Impact factor: 4.792

10.  Identification of volatile biomarkers of Giardia duodenalis infection in children with persistent diarrhoea.

Authors:  C Ubeda; E Lepe-Balsalobre; C Ariza-Astolfi; J M Ubeda-Ontiveros
Journal:  Parasitol Res       Date:  2019-10-12       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.